查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378799

脑膜炎双球菌疫苗市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Meningococcal Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年，全球脑膜炎双球菌疫苗市场规模达到33亿美元。展望未来， IMARC Group预计到2028年市场规模将达到55亿美元，2022-2028年复合年增长率（CAGR）为8.9%。

脑膜炎双球菌疫苗是指用于预防脑膜炎的生物物质，脑膜炎是脊髓和大脑周围膜的传染性感染。脑膜炎双球菌疫苗的三种主要类型包括结合疫苗、多醣体疫苗和荚膜下脑膜炎双球菌疫苗。给婴儿、儿童和成人注射疫苗，使他们对侵袭性疾病产生免疫，并针对脑膜炎球菌 A、B、C、W-135 和 Y。注射疫苗后，会形成抗体来对抗细菌并产生免疫反应以防止日后感染。

全球幼儿和青少年中脑膜炎球菌疾病的盛行率不断上升，是推动市场成长的关键因素之一。此外，群众健康意识的提高和常规免疫接种的采用也为市场成长提供了动力。脑膜炎双球菌疫苗有助于预防这种疾病并最大限度地减少长期影响，例如暂时或永久性耳聋、视力和运动技能丧失、癫痫发作和神经损伤。为此，已开发经济体和新兴经济体政府都在启动广泛的公共卫生计划，同时强调对游客和军人等特殊风险群体进行免疫接种，以控制感染风险。此外，各种产品创新，例如开发不需要重构的即用型液体配方，也有助于市场成长。其他因素，包括广泛的研发（R&D）活动以及医疗保健基础设施的改善，预计将进一步推动市场发展。

本报告回答的关键问题：

  • 迄今为止，全球脑膜炎双球菌疫苗市场表现如何，未来几年将如何表现？
  • COVID-19 对全球脑膜炎双球菌疫苗市场有何影响？
  • 主要区域市场有哪些？
  • 根据疫苗类型，市场的细分情况如何？
  • 根据构成，市场的细分是怎样的？
  • 根据疫苗血清型的市场划分是怎样的？
  • 基于配销通路的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球脑膜炎双球菌疫苗市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球脑膜炎双球菌疫苗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按疫苗类型分類的市场区隔

  • 共轭
    • 市场走向
    • 市场预测
  • 多醣
    • 市场走向
    • 市场预测
  • 被膜下
    • 市场走向
    • 市场预测

第 7 章：依构成分類的市场

  • 单一疫苗
    • 市场走向
    • 市场预测
  • 联合疫苗
    • 市场走向
    • 市场预测

第 8 章：以疫苗血清型分類的市场

  • 男子ACWY
    • 市场走向
    • 市场预测
  • MenB & 狂躁
    • 市场走向
    • 市场预测
  • 门C
    • 市场走向
    • 市场预测
  • 甲型肝炎
    • 市场走向
    • 市场预测
  • 男性AC
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按配销通路分類的市场区隔

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 机构销售
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章：最终用户的市场区隔

  • 儿科
    • 市场走向
    • 市场预测
  • 成人
    • 市场走向
    • 市场预测

第 11 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • GlaxoSmithKline Plc
    • Hualan Biological Engineering Inc.
    • Incepta Pharmaceuticals Limited
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Serum Institute of India Ltd.
    • Walvax Biotechnology Co. Ltd.
Product Code: SR112023A2730

Abstract

The global meningococcal vaccines market size reached US$ 3.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.9% during 2022-2028.

Meningococcal vaccine refers to a biological substance administered for the prevention of meningitis, which is a contagious infection of the membranes surrounding the spinal cord and the brain. The three main kinds of meningococcal vaccines include conjugate, polysaccharide and subcapsular meningococcal vaccines. They are administered to infants, children and adults to immunize them against the invasive disease and target meningococcal bacteria A, B, C, W-135 and Y. Once the vaccine is administered, antibodies are formed to fight the bacteria and create an immune response to prevent the infection in the future.

The increasing prevalence of the meningococcal disease among young children and adolescents across the globe represents one of the key factors driving the growth of the market. Furthermore, the rising health consciousness among the masses and the adoption of routine immunization are providing a thrust to the market growth. Meningococcal vaccine aids in preventing the disease and minimizing the long-term effects, such as temporary or permanent deafness, loss of vision and motor skills, seizure and neurological damage. In line with this, governments of both developed and emerging economies are launching extensive public health programs while emphasizing on the immunization of special risk groups, such as tourists and military personnel, to contain the risks of infections. Additionally, various product innovations, such as the development of ready-to-use liquid formulations that do not require reconstitution, are also contributing to the market growth. Other factors, including extensive research and development (R&D) activities, along with improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global meningococcal vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, composition, vaccine serotype, distribution channel and end user.

Breakup by Vaccine Type:

Conjugate

Polysaccharide

Subcapsular

Breakup by Composition:

Mono Vaccines

Combination Vaccines

Breakup by Vaccine Serotype:

MenACWY

MenB & Manic

MenC

MenA

MenAC

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Institutional Sales

Others

Breakup by End User:

Pediatric

Adult

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being GlaxoSmithKline Plc, Hualan Biological Engineering Inc., Incepta Pharmaceuticals Limited, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Ltd. and Walvax Biotechnology Co. Ltd.

Key Questions Answered in This Report:

  • How has the global meningococcal vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global meningococcal vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the composition?
  • What is the breakup of the market based on the vaccine serotype?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global meningococcal vaccines market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Meningococcal Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Conjugate
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Polysaccharide
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Subcapsular
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Composition

  • 7.1 Mono Vaccines
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Combination Vaccines
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Vaccine Serotype

  • 8.1 MenACWY
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 MenB & Manic
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 MenC
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 MenA
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 MenAC
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Retail Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Institutional Sales
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Pediatric
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Adult
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 GlaxoSmithKline Plc
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Hualan Biological Engineering Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Incepta Pharmaceuticals Limited
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Novartis AG
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Pfizer Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Sanofi S.A.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Serum Institute of India Ltd.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Walvax Biotechnology Co. Ltd.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials

List of Figures

  • Figure 1: Global: Meningococcal Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Meningococcal Vaccines Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Meningococcal Vaccines Market: Breakup by Vaccine Type (in %), 2022
  • Figure 4: Global: Meningococcal Vaccines Market: Breakup by Composition (in %), 2022
  • Figure 5: Global: Meningococcal Vaccines Market: Breakup by Vaccine Serotype (in %), 2022
  • Figure 6: Global: Meningococcal Vaccines Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Meningococcal Vaccines Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Meningococcal Vaccines Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Meningococcal Vaccines Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 10: Global: Meningococcal Vaccines (Conjugate) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Meningococcal Vaccines (Conjugate) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Meningococcal Vaccines (Polysaccharide) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Meningococcal Vaccines (Polysaccharide) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Meningococcal Vaccines (Subcapsular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Meningococcal Vaccines (Subcapsular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Meningococcal Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Meningococcal Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Meningococcal Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Meningococcal Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Meningococcal Vaccines (MenACWY) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Meningococcal Vaccines (MenACWY) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Meningococcal Vaccines (MenB & Manic) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Meningococcal Vaccines (MenB & Manic) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Meningococcal Vaccines (MenC) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Meningococcal Vaccines (MenC) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Meningococcal Vaccines (MenA) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Meningococcal Vaccines (MenA) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Meningococcal Vaccines (MenAC) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Meningococcal Vaccines (MenAC) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Meningococcal Vaccines (Other Vaccine Serotypes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Meningococcal Vaccines (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Meningococcal Vaccines (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Meningococcal Vaccines (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Meningococcal Vaccines (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Meningococcal Vaccines (Institutional Sales) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Meningococcal Vaccines (Institutional Sales) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Meningococcal Vaccines (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Meningococcal Vaccines (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Meningococcal Vaccines (Pediatric) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Meningococcal Vaccines (Pediatric) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Meningococcal Vaccines (Adult) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Meningococcal Vaccines (Adult) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: North America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: North America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: United States: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: United States: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Canada: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Canada: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Asia Pacific: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Asia Pacific: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: China: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: China: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Japan: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Japan: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: India: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: India: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: South Korea: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: South Korea: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Australia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Australia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Indonesia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Indonesia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Europe: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Europe: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Germany: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Germany: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: France: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: France: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: United Kingdom: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: United Kingdom: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Italy: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Italy: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Spain: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Spain: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Russia: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Russia: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Latin America: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Latin America: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Brazil: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Brazil: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Mexico: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Mexico: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Others: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Others: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Middle East and Africa: Meningococcal Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Middle East and Africa: Meningococcal Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Global: Meningococcal Vaccines Industry: SWOT Analysis
  • Figure 93: Global: Meningococcal Vaccines Industry: Value Chain Analysis
  • Figure 94: Global: Meningococcal Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Meningococcal Vaccines Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
  • Table 3: Global: Meningococcal Vaccines Market Forecast: Breakup by Composition (in Million US$), 2023-2028
  • Table 4: Global: Meningococcal Vaccines Market Forecast: Breakup by Vaccine Serotype (in Million US$), 2023-2028
  • Table 5: Global: Meningococcal Vaccines Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 6: Global: Meningococcal Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 7: Global: Meningococcal Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Meningococcal Vaccines Market: Competitive Structure
  • Table 9: Global: Meningococcal Vaccines Market: Key Players